Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-09-17 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
EXTENSION OF LONG STOP DATE OF CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF NEW SHARES UNDER GENERAL MANDATE AND FURTHER DELAY IN DESPATCH OF CIRCULAR
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding an extension of the long stop date for connected transactions involving loan capitalisation and the issue of new shares under a general mandate. It also mentions a further delay in the dispatch of a circular containing detailed information about these transactions, including advice from independent committees and a notice of an extraordinary general meeting (EGM). The document is relatively short (4618 characters) and serves as an update on the status of these transactions and the timing of the circular, rather than containing the full circular or detailed financial data. It is not a full financial report, earnings release, or proxy solicitation itself, but an announcement about the delay in dispatching such materials. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to financing activities and capital structure changes (loan capitalisation and share issuance).
2021-09-17 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a board meeting scheduled to consider and approve the annual results for the year ended 30 June 2021 and the payment of a final dividend. The text does not contain the actual annual results or financial data but merely announces the upcoming board meeting where these will be considered and published. The document length is short (2424 characters), and it serves as a notification rather than a report itself. According to the 'MENU VS MEAL' rule, this is an announcement about the timing of a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2021-09-16 English
ANNOUNCEMENT MADE PURSUANT TO RULE 17.50(2)(L) AND RULE 17.50A(2) OF THE GEM LISTING RULES
Board/Management Information Classification · 100% confidence The document is an announcement made pursuant to specific GEM Listing Rules (Rule 17.50(2)(l) and Rule 17.50A(2)) regarding a change in information related to a director, Mr. Lau Fai Lawrence. It details his involvement with another company undergoing winding up proceedings and confirms that this does not affect the company making the announcement. The content focuses on disclosure about a director's external affairs and compliance with listing rules about director information updates. There is no financial data, no report attached or referenced as published, and no mention of financial results or management reports. This fits the category of Board/Management Information (MANG), which covers announcements of changes or updates related to the company's board of directors or senior management.
2021-09-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2021
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on share capital, issued shares, share options, convertible bonds, and confirmations related to securities issued by Sinopharm Tech Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, reporting on share capital changes and confirmations but does not contain financial statements, management discussion, or earnings data. It is not an announcement of a report but a regulatory filing itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-09-06 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO GRANT OF SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is a supplemental announcement related to the grant of share options, providing additional details about the identities of consultants granted options and the number of options granted. It references a previous announcement dated 27 August 2021. The document is relatively short (4361 characters) and serves as an update or clarification rather than a full report. It does not contain financial statements or detailed financial analysis. The content focuses on share option grants, which relates to capital changes but is specifically an announcement supplementing a prior announcement. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes such as share options.
2021-09-02 English
COMPLETION OF THE ISSUE OF CONVERTIBLE BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the completion of the issue of convertible bonds. It details the terms, shareholding structure effects, and amendments related to the convertible bonds. The document is not a full financial report but rather a specific update on a financing event. It does not contain comprehensive financial statements or management discussion but focuses on the capital raising activity and its impact on shareholding. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is over 10,000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2021-08-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.